Eric Edidin

Eric Edidin is an advisor at GVNG and a board member at Spartacus Acquisition Corporation. Eric was previously with ILiAD Biotechnologies, LLC, BH3 Management, and Capillary Biomedical.

At Capillary Biomedical, Eric served as a board observer from January 2020 to July 2022. During their time there, they helped the company develop technologies for diabetes management, including the patent-pending SteadiSet infusion set for insulin pump therapy.

Eric has been instrumental in helping various businesses grow and develop over the years. Eric's experience and expertise have made him a valuable asset to any team.

Eric Edidin graduated with a BBA from the University of Michigan in finance and accounting. Eric then went on to obtain their MBA from Harvard Business School.